(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CELFORPHARMA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

CELFORPHARMA

ST13

US500000099004087

Classe

35, 41, 42

Pedido

99004087

Registro

8046926

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

24

Atualização mais recente

11/03/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

35, 41, 42

Data de depósito

16/01/2025

Data de registro

02/12/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

02/12/2025

Última transação

11/03/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Código do desenho

3

Tipo de titular

99

Localização do titular

Machelen, BE

Examinador

FOSBERG, MADELEINE E

Unidade examinadora

N90

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of the stylized wording "CELFORPHARMA" in black, with a partial circle border around the letters "CEL" comprised of four curving rectangles in the colors orange, green, blue and gray. The color white is merely background and not claimed as a feature of the mark.

Titulares e representantes

Titulares

CELforPharma B.V.

Representantes

Michael C. Cerrati Belzer PC

Classificação técnica

Classes Nice

Classe 35Classe 41Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Advertising services; Business management; Business administration; Providing office functions relating to the coordination of applications for coursesworkshopstraining and training courses for the pharmaceutical industry; Marketing services; Market canvassing in the nature of market research and market analysis services for the pharmaceutical industry; business economics consultancybusiness organization consultancybusiness administration consultancyall for the pharmaceutical industry; Office functions in the nature of maintainingcollectingmanaging and updating data files for others in the pharmaceutical industry; Arranging special events for publicity or commercial purposes for the pharmaceutical industry; Consultancy and information regarding the aforesaid services; The aforesaid services also provided via electronic networkssuch as the Internet

Classe 41

Education servicesarranging and conducting of seminarsinstruction coursesworkshopscongressestraining seminarslectureseducational courses for managers in the pharmaceutical industry and in the fields of business developmentmarket forecastingmarket penetrationrisk analysisstrategy and brand development; Providing of training in the pharmaceutical industry and in the fields of business developmentmarket forecastingmarket penetrationrisk analysisstrategy and brand development; Educational and entertainment servicesproviding continuing programs in the pharmaceutical industry and in the fields of business developmentmarket forecastingmarket penetrationrisk analysisstrategy and brand development accessible live and via audiovideo and web-based applications; Publishing and lending of booksjournalsnewspapersmagazinesarticlespress releasesleafletsbrochuresinformation bulletins and other printed matter and periodicalsaudiovisual and multimedia products in the field of pharmaceuticals for the pharmaceutical industry; Providing non-downloadable electronic publications in the nature of booksjournalsnewspapersmagazinesarticlespress releasesleafletsbrochuresinformation bulletins and other printed matter and periodicals in the field of pharmaceuticals for the pharmaceutical industry from a global computer network or the Internet; Publication of electronic books and journals online; Publication of textsother than publicity texts; Translation and language interpretation; Educational services in the fields of science and technologyeducation research and developing teaching materials for coursesworkshopstraining and training courses for the pharmaceutical industry; Consultancy and information regarding the aforesaid services; The aforesaid services also provided via electronic networkssuch as the Internet

Classe 42

Scientific and technological servicesresearch and new product design for the pharmaceutical industry in the field of pharmaceuticals; Consultancy and information regarding the aforesaid services; The aforesaid services also provided via electronic networkssuch as the Internet

Publicações

Histórico de despachos e eventos da marca no USPTO.

24 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/12/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/12/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/10/2025

PUBO

PUBLISHED FOR OPPOSITION

14/10/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/10/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/09/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

13/09/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

13/09/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

13/09/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

13/09/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

12/09/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/09/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

12/09/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/09/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/09/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/09/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/09/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

28/06/2025

GNRT

NON-FINAL ACTION E-MAILED

28/06/2025

CNRT

NON-FINAL ACTION WRITTEN

28/06/2025

DOCK

ASSIGNED TO EXAMINER

26/06/2025

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

18/06/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

18/06/2025

NWAP

NEW APPLICATION ENTERED

17/01/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CELFORPHARMA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.